Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DE BROUCKERE from Brussel, company number BE0881900640, closed financial year 2025 with a result of € -8,548 after tax. For that financial year PHARMACIE DE BROUCKERE recorded a gross margin of € 132,060 and equity of € 1,868. Compared with financial year 2024, the result moved from € 6,768 to € -8,548. The company made a loss. The buffer shrank hard: equity is 82 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 1,868
▼ 82% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -8,548
▼ still € 6,768 profit in 2024
Profit after tax over the fiscal year.
€ 57,308
▲ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4,332.
People and assets in 2025
1.5
Average over the fiscal year, from the social balance sheet.
€ 116,538
€ 77,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 117,287
▲ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,629
▲ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 96,220 | € 140,394 | € 125,112 | € 132,060 | ▲ 6% |
| Profit after taxes | € -1,680 | € 21,801 | € 6,768 | € -8,548 | ▼ € 15,316 |
| Equity | € -18,153 | € 3,648 | € 10,417 | € 1,868 | ▼ 82% |
| Total debts | € 321,987 | € 282,649 | € 277,721 | € 298,451 | ▲ 7% |
| Cash | € 115,902 | € 50,811 | € 53,369 | € 57,308 | ▲ 7% |
| Retained profit | € -24,353 | € -2,552 | € 4,217 | € -4,332 | ▼ € 8,548 |
| Balance sheet total | € 303,834 | € 286,297 | € 288,137 | € 300,319 | ▲ 4% |
| Employees (FTE) | 1.5 | 1.5 | 1.5 | 1.5 |
Key figures of PHARMACIE DE BROUCKERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE BROUCKERE?
What happened at PHARMACIE DE BROUCKERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 8,548 (▼ € 15,316 vs 2024). Source: NBB ↗
- Marevapo BV became a director. NBB
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,680 loss in 2022 to € 8,548 loss in 2025.
Paid € 2 in corporate taxes since 2022.
Best year ever: 2023, with € 21,801 profit.
On average € 88,000 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE BROUCKERE? We notify you, reason included.
Follow PHARMACIE DE BROUCKEREDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Marevapo comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DE BROUCKEREBehind PHARMACIE DE BROUCKERE is Marevapo BV. The shares are held by Marevapo (100%).
Directors
According to the 2025 annual accounts
since 2013
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorddoorgang 10 box 12
1000 Brussel
Noorddoorgang 10
1000 Brussel
Active since 1 January 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0881.900.640
- VAT number
- BE 0881.900.640
- Registered office
- Noorddoorgang 10 bus 12, 1000 Brussel
- Names & denominations
- PHARMACIE DE BROUCKERE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 June 2006
- Peppol
- Active · Active since 1 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers